Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
264 LiuCGuoXBaiSZengGWangH
Enrollment in any plan depends on contract renewal
Glucagon-Like Peptide-1 Receptor Agonist Use and the Risk of Adverse Cardiac and Kidney Outcomes Among Patients with Systemic Lupus Erythematosus and Lupus Nephritis
NICHOLAS P ALVAREZ (Chief Acquisition Officer) sold 75,000 shares for an estimated $443,760 ERIC HAROLD YECIES (Chief Legal Officer & GC) sold 15,000 shares for an estimated $183,750 To track insider transactions, check out Quiver Quantitative's insider trading dashboard
US$ 21.05
US$ 24.44
US$ 21.06
